Guidelines for bioinformatics of single-cell sequencing data analysis in Alzheimer's disease: review, recommendation, implementation and application

M Wang, W Song, C Ming, Q Wang, X Zhou… - Molecular …, 2022 - Springer
Alzheimer's disease (AD) is the most common form of dementia, characterized by
progressive cognitive impairment and neurodegeneration. Extensive clinical and genomic …

COVID-19 and human reproduction: A pandemic that packs a serious punch

G Anifandis, HG Tempest, R Oliva… - Systems Biology in …, 2021 - Taylor & Francis
The COVID-19 pandemic has led to a worldwide health emergency that has impacted 188
countries at last count. The rapid community transmission and relatively high mortality rates …

Efficacious preclinical repurposing of the nucleoside analogue didanosine against COVID-19 polymerase and exonuclease

AM Rabie - ACS omega, 2022 - ACS Publications
Analogues and derivatives of natural nucleosides/nucleotides are considered among the
most successful bioactive species of drug-like compounds in modern medicinal chemistry …

The COVID-19 drug and gene set library

MV Kuleshov, DJ Stein, DJB Clarke, E Kropiwnicki… - Patterns, 2020 - cell.com
In a short period, many research publications that report sets of experimentally validated
drugs as potential COVID-19 therapies have emerged. To organize this accumulating …

ASGARD is a single-cell guided pipeline to aid repurposing of drugs

B He, Y **ao, H Liang, Q Huang, Y Du, Y Li… - Nature …, 2023 - nature.com
Single-cell RNA sequencing technology has enabled in-depth analysis of intercellular
heterogeneity in various diseases. However, its full potential for precision medicine has yet …

Advances in the computational landscape for repurposed drugs against COVID-19

I Aronskyy, Y Masoudi-Sobhanzadeh, A Cappuccio… - Drug Discovery …, 2021 - Elsevier
The COVID-19 pandemic has caused millions of deaths and massive societal distress
worldwide. Therapeutic solutions are urgently needed, but de novo drug development …

[HTML][HTML] Current understanding of nucleoside analogs inhibiting the SARS-CoV-2 RNA-dependent RNA polymerase

T Xu, L Zhang - Computational and Structural Biotechnology Journal, 2023 - Elsevier
Since the outbreak of the COVID-19 pandemic, severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) RNA-dependent RNA polymerase (RdRp) has become a main …

How do we share data in COVID-19 research? A systematic review of COVID-19 datasets in PubMed Central Articles

X Zuo, Y Chen, L Ohno-Machado… - Briefings in …, 2021 - academic.oup.com
Objective This study aims at reviewing novel coronavirus disease (COVID-19) datasets
extracted from PubMed Central articles, thus providing quantitative analysis to answer …

Bisindolylmaleimide IX: A novel anti-SARS-CoV2 agent targeting viral main protease 3CLpro demonstrated by virtual screening pipeline and in-vitro validation assays

Y Gupta, D Maciorowski, SE Zak, KA Jones… - Methods, 2021 - Elsevier
Abstract SARS-CoV-2, the virus that causes COVID-19 consists of several enzymes with
essential functions within its proteome. Here, we focused on repurposing approved and …

A review on the interaction of nucleoside analogues with SARS-CoV-2 RNA dependent RNA polymerase

S Khan, F Attar, SH Bloukh, M Sharifi, F Nabi… - International Journal of …, 2021 - Elsevier
The outbreaks of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) in 2019,
have highlighted the concerns about the lack of potential vaccines or antivirals approved for …